NO862170L - Fremstilling av quinazolinderivater. - Google Patents

Fremstilling av quinazolinderivater.

Info

Publication number
NO862170L
NO862170L NO862170A NO862170A NO862170L NO 862170 L NO862170 L NO 862170L NO 862170 A NO862170 A NO 862170A NO 862170 A NO862170 A NO 862170A NO 862170 L NO862170 L NO 862170L
Authority
NO
Norway
Prior art keywords
group
heteroatom
quinazoline derivatives
preparation
halogeno
Prior art date
Application number
NO862170A
Other languages
English (en)
Norwegian (no)
Inventor
Ann Lesley Jackman
Richard Newell
Richard Jones
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of NO862170L publication Critical patent/NO862170L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO862170A 1985-05-31 1986-05-30 Fremstilling av quinazolinderivater. NO862170L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858513754A GB8513754D0 (en) 1985-05-31 1985-05-31 Anti-cancer quinazoline derivatives

Publications (1)

Publication Number Publication Date
NO862170L true NO862170L (no) 1986-12-01

Family

ID=10579966

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862170A NO862170L (no) 1985-05-31 1986-05-30 Fremstilling av quinazolinderivater.

Country Status (17)

Country Link
US (1) US5236927A (de)
EP (1) EP0204529B1 (de)
JP (1) JPS61282368A (de)
AT (1) ATE87621T1 (de)
AU (1) AU592271B2 (de)
DE (1) DE3688150T2 (de)
DK (1) DK255786A (de)
ES (1) ES8800911A1 (de)
FI (1) FI862303A7 (de)
GB (2) GB8513754D0 (de)
GR (1) GR861418B (de)
HU (1) HUT45512A (de)
IL (1) IL78910A0 (de)
NO (1) NO862170L (de)
NZ (1) NZ216363A (de)
PT (1) PT82682B (de)
ZA (1) ZA864051B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
GB8707053D0 (en) * 1987-03-25 1987-04-29 Ici Plc Anti-tumour agents
US4857530A (en) * 1987-11-03 1989-08-15 Warner-Lambert Company Substituted quinazolinones as anticancer agents
GB8809978D0 (en) * 1988-04-27 1988-06-02 Ici Plc Anti-tumour agents
EP0365763A1 (de) * 1988-09-30 1990-05-02 Agouron Pharmaceuticals, Inc. Zyklische Verbindungen als Antiproleferahne
US5286726A (en) * 1990-04-12 1994-02-15 The Regents Of The University Of Michigan Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
US6762188B1 (en) 1990-06-19 2004-07-13 Smithkline Beecham Corporation Pharmaceutically active benzoquinazoline compounds
GB9105771D0 (en) * 1991-03-19 1991-05-01 Cancer Res Inst Royal Anti-cancer compounds
GB9205320D0 (en) * 1992-03-11 1992-04-22 Ici Plc Anti-tumour compounds
GB9205907D0 (en) * 1992-03-18 1992-04-29 Cancer Res Inst Royal Anti-cancer compounds
US5430148A (en) * 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
GB9223352D0 (en) * 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
US7262058B2 (en) * 2001-03-09 2007-08-28 Nonda Katopodis Method for determining lipid associated sialoprotein in body fluids
US20060047952A1 (en) * 2002-10-18 2006-03-02 Koninklijke Philips Electronics, N.V. Method, system, device , signal and computer program product for metadata protection in tv-anytime
WO2004041755A2 (en) * 2002-11-04 2004-05-21 Nps Pharmaceuticals, Inc. Quinazolinone compounds as calcilytics
WO2007011618A1 (en) * 2005-07-15 2007-01-25 Schering Corporation Quinazoline derivatives useful in cancer treatment
CN101263125A (zh) * 2005-07-15 2008-09-10 先灵公司 用于癌症治疗的喹唑啉衍生物
CA2663436A1 (en) 2006-10-04 2008-04-10 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
TWI469971B (zh) 2007-10-26 2015-01-21 Univ California 二芳基乙內醯脲類化合物
PT2445502T (pt) 2009-06-25 2017-09-22 Alkermes Pharma Ireland Ltd Compostos heterocíclicos para o tratamento de distúrbios neurológicos e psicológicos
EP2521711B1 (de) * 2010-01-07 2017-08-16 Alkermes Pharma Ireland Limited Quartäre ammoniumsalz-prodrugs
NZ604423A (en) 2010-06-24 2015-01-30 Alkermes Pharma Ireland Ltd Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
ES2972387T3 (es) 2011-03-18 2024-06-12 Alkermes Pharma Ireland Ltd Composiciones farmacéuticas que comprenden ésteres de sorbitán
CA2867121C (en) 2012-03-19 2021-05-25 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising fatty acid esters
WO2013142202A1 (en) 2012-03-19 2013-09-26 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising glycerol esters
US9999670B2 (en) 2012-03-19 2018-06-19 Alkermes Pharma Ireland Limited Pharmaceutical compositions comprising benzyl alcohol
JP6654042B2 (ja) 2012-09-19 2020-02-26 アルカームス ファーマ アイルランド リミテッド 貯蔵安定性が改善された医薬組成物
AU2015231278B2 (en) 2014-03-20 2020-01-23 Alkermes Pharma Ireland Limited Aripiprazole formulations having increased injection speeds
AU2019230014B2 (en) 2018-03-05 2024-11-28 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
WO2024028999A1 (ja) * 2022-08-03 2024-02-08 Ils株式会社 Ｎ－［４－メチルアミノベンゾイル］－ｌ－グルタミン酸ジエチルエステルの製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1021196A (en) * 1964-02-20 1966-03-02 Parke Davis & Co Novel amino acids and means for producing the same
US3471498A (en) * 1967-08-11 1969-10-07 Parke Davis & Co Certain n-p-((2,4-diamino-6-quinazolinyl)-methyl)benzoylamino acids
EP0031237B1 (de) * 1979-12-19 1984-10-17 National Research Development Corporation Chinazolinderivate, Verfahren zu ihrer Herstellung, sie enthaltende Zusammensetzungen und ihre Verwendung als Anti-Krebs-Mittel
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents

Also Published As

Publication number Publication date
GB8513754D0 (en) 1985-07-03
GB8613184D0 (en) 1986-07-02
ES555548A0 (es) 1987-12-01
US5236927A (en) 1993-08-17
DE3688150D1 (de) 1993-05-06
DE3688150T2 (de) 1993-07-29
AU5822086A (en) 1986-12-04
HUT45512A (en) 1988-07-28
EP0204529B1 (de) 1993-03-31
ATE87621T1 (de) 1993-04-15
NZ216363A (en) 1989-07-27
AU592271B2 (en) 1990-01-04
FI862303A0 (fi) 1986-05-30
PT82682B (pt) 1988-03-03
IL78910A0 (en) 1986-09-30
DK255786D0 (da) 1986-05-30
ZA864051B (en) 1987-01-28
ES8800911A1 (es) 1987-12-01
FI862303A7 (fi) 1986-12-01
DK255786A (da) 1986-12-01
GB2175903A (en) 1986-12-10
JPS61282368A (ja) 1986-12-12
PT82682A (en) 1986-06-01
GR861418B (en) 1986-09-26
EP0204529A3 (en) 1987-11-19
GB2175903B (en) 1988-10-12
EP0204529A2 (de) 1986-12-10

Similar Documents

Publication Publication Date Title
DE3688150D1 (de) Antikrebs-chinazolinon-derivate.
MX166257B (es) Composicion de revestimiento que contiene grupos de carbamato de hidroxialquilo
IE802672L (en) Quinazolines
ES2066991T3 (es) Agentes hipoglucemiantes de oxazolidinadiona.
DE3784501D1 (de) Wasserabweisendes mittel fuer bauwerke.
DK345989A (da) Quinolinderivater
IT1200011B (it) Agente immunomodulante
DE3772015D1 (de) Chinolinverbindung.
AR247744A1 (es) Compuestos organosilano y catalizadores que contienen dichos compuestos
ES2055384T3 (es) Compuestos dioxafosforinanos y composiciones poliolefinicas estabilizadas con ellos.
MX170732B (es) Composicion de derivados de succinimida y su uso
DE3661198D1 (en) Phosphate ester derivatives, and their use as anti-cancer agents
DE69213656D1 (de) 1-Alkyl-2-Acyl-1,2-Disulfonylhydrazine mit antineoplastischer Aktivität
DE3688128D1 (de) Isoindolinderivate und verfahren zu ihrer herstellung.
DK439286A (da) Propanolderivater
GR3001491T3 (en) Fungicides